$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Upregulation of Type III endothelial cell nitric oxide synthase by rho GTPase function inhibitors 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-038/02
  • A61K-038/45
  • A61K-039/395
출원번호 US-0132849 (1998-08-11)
발명자 / 주소
  • Liao James K.
출원인 / 주소
  • Brigham and Women's Hospital, Inc.
대리인 / 주소
    Wolf, Greenfield & Sacks, P.C.
인용정보 피인용 횟수 : 20  인용 특허 : 41

초록

A use for rho GTPase function inhibitors is provided. In the instant invention, rho GTPase function inhibitors are found to upregulate endothelial cell Nitric Oxide Synthase activity. As a result, rho GTPase function inhibitors are useful in treating or preventing conditions that result from the abn

대표청구항

[ We claim:] [1.] A method for treating a subject to increase endothelial cell Nitric Oxide Synthase activity in a tissue, comprising:administering to a subject in need of such treatment a rho GTPase function inhibitor in an amount effective to increase endothelial cell Nitric Oxide Synthase activit

이 특허에 인용된 특허 (41)

  1. Glamkowski Edward J. (Warren NJ) Fortunato James M. (North Wales PA), 1-(Aminoalkylphenyl and aminoalkylbenzyl)-indoles and indolines and analgesic method of use thereof.
  2. Hoffman William F. (Lansdale PA) Smith Robert L. (Lansdale PA) Willard Alvin K. (Wilmington DE), Antihypercholesterolemic compounds.
  3. Hoffman William F. (Wilmington Lansdale PA) Smith Robert L. (Wilmington Lansdale PA) Willard Alvin K. (Wilmington DE), Antihypercholesterolemic compounds.
  4. Wareing James R. (Randolph NJ), Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives.
  5. Cooke John P. ; Dzau Victor J. ; Gibbons Gary H., Enhancement of vascular function by modulation of endogenous nitric oxide production or activity.
  6. Anderson Paul L. (Randolph NJ), Erythro-(E)-7-[3′-C1-3alkyl-1′-(3″,5″-dimethylphenyl)naphth-2′-yl]-3,5-dihydroxyhept-6-enoic acids an.
  7. Bradfute David L. (Wooster OH) Simoni Robert D. (Palo Alto CA), Farnesyl compounds as cholesterol lowering agents.
  8. Smith Robert L. (Lansdale PA) Halczenko Wasyl (Hatfield PA) Hartman George D. (Lansdale PA) Stokker Gerald E. (Gwynedd Valley PA) Inamine Edward S. (Rahway NJ) Hensens Otto D. (Red Bank NJ) Houck Dav, HMG-CoA reductase inhibitors.
  9. Monaghan Richard L. (Somerset NJ) Alberts Alfred W. (Short Hills NJ) Hoffman Carl H. (Scotch Plains NJ) Albers-Schonberg George (Princeton NJ), Hypocholesteremic fermentation products and process of preparation.
  10. Patchett Arthur A. (Westfield NJ) Kuo Chan-Hwa (South Plainfield NJ), Hypocholesterolemic hydrogenation products and process of preparation.
  11. Kathawala Faizulla G. (Mountain Lakes NJ), Indole analogs of mevalonolactone and derivatives thereof.
  12. Sebti Said (Pittsburgh PA) Hamilton Andrew (Pittsburgh PA) Seong Churl M. (Pittsburgh PA), Inhibition of farnesyltransferase.
  13. Gibbs Jackson B. (Chalfont PA) Graham Samuel L. (Schwenksville PA), Inhibitors of geranylgeranyl-protein transferase.
  14. Kathawala Faizulla G. (Mountain Lakes NJ), Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof.
  15. Terahara Akira (Hiromachi JPX) Tanaka Minoru (Hiromachi JPX), ML-236B Derivatives and their preparation.
  16. Nambi Ponnal (Berwyn PA) Patil Ashok D. (King of Prussia PA), Medicament.
  17. Kaesemeyer Wayne H., Method and formulation for treating vascular disease.
  18. Kaesemeyer W. H., Method and formulation of stimulating nitric oxide synthesis.
  19. Kaesemeyer W. H. (2433 McDowell St. August GA 30904), Method and formulation of stimulating nitric oxide synthesis.
  20. Olukotun Adeove Y. (Hopewell NJ) Alexander John C. (Winnetka IL), Method for preventing a second heart attack employing an HMG CoA reductase inhibitor.
  21. Tschollar Werner (Lawrenceville NJ) Yonce Cary S. (Newtown PA) Bergey James L. (Lansdale PA) Kawano James C. (Narberth PA), Method for preventing onset of hypertension employing a cholesterol lowering drug.
  22. Tschollar Werner (Lawrenceville NJ) Yonce Cary S. (Newtown PA) Bergey James L. (Lansdale PA) Kawano James C. (Narberth PA), Method for preventing onset of hypertension employing a cholesterol lowering drug.
  23. Hirsch Gerald P. (Atlanta GA) Bayless Robert K. (Austin TX), Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds.
  24. Baran John S. (Winnetka IL) Liang Chi-Dean (Glenview IL), Octahydronapthalenes.
  25. Joshi Yatindra M. (Piscataway NJ) Chiesa Pierina (South Orange NJ) Jain Nemichand B. (Monmouth Junction NJ), Pharmaceutical compositions having good stability.
  26. Nakajima Masahide (Hirakata JPX) Nakamura Norifumi (Hirakata JPX) Wang Feng (Hirakata JPX) Yamanouchi Koichi (Hirakata JPX) Hayashi Kazutaka (Hirakata JPX) Kido Hideaki (Hirakata JPX) Kubo Yoshiji (H, Pharmaceutical use of dihydropyridine derivative.
  27. Murugesan Natesan (Lawrenceville NJ) Hunt John T. (Princeton NJ) Stein Philip D. (Princeton NJ), Phenyl sulfonamide endothelin antagonists.
  28. Endo Akira (Tokyo JA) Kuroda Masao (Tokyo JA) Terahara Akira (Tokyo JA) Tsujita Yoshio (Tokyo JA) Tamura Chihiro (Tokyo JA), Physiologically active substances.
  29. Joshi Yatindra M. (Piscataway NJ) Chiesa Pierina (South Orange NJ) Jain Nemichand B. (Monmouth Junction NJ), Pravastatin pharmaceuatical compositions having good stability.
  30. Chen Shieh-Shung J. (Morganville NJ) Arison Byron H. (Watchung NJ), Process for the preparation of 3-keto, 5-hydroxy simvastatin analogs.
  31. Heath ; Jr. William F. (Fishers IN) McDonald ; III John H. (Carmel IN) Paal Michael (Hamburg DEX) Ruhter Gerd (Hamburg DEX) Schotten Theo (Vierhofen DEX) Stenzel Wolfgang (Reinbek DEX), Protein kinase C inhibitors.
  32. Kleinschroth Jrgen (Denzlingen DEX) Hartenstein Johannes (Stegen-Wittental DEX) Schchtele Christoph (Freiburg DEX) Rudolph Claus (Vrstetten DEX) Dooley David J. (Freiburg DEX) Weinheimer Gnther (Denz, Pyrrolocarbazole derivatives, compositions containing them, and methods for using them.
  33. Alberts Alfred W. (Princeton NJ) Berger Gregory D. (Belle Meade NJ) Bergstrom James D. (Neshanic Station NJ), Squalene synthetase inhibitors.
  34. Murugesan Natesan (Lawrenceville NJ), Substituted biphenyl isoxazole sulfonamides.
  35. Jirousek Michael R. ; Heath ; Jr. William Francis ; Ways Douglas Kirk ; Stramm Lawrence E., Therapeutic treatment for cardiovascular diseases.
  36. Lane Ronald H. (Phoenix AZ) Qureshi Asaf A. (Madison WI) Salser Winston A. (Pacific Palisades CA), Tocotrienols and tocotrienol-like compounds and methods for their use.
  37. Maiese Kenneth (New York NY) Wagner John A. (New York NY), Treatment of stroke or in anticipation of the occurrence of brain ischemia.
  38. Cooke John P. (Palo Alto CA) Dzau Victor J. (Los Altos Hills CA) Gibbons Gary H. (Palo Alto CA), Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity.
  39. Cooke John P. ; Dzau Victor J. ; Gibbons Gary H., Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity.
  40. Vedder Nicholas B. ; Nudelman Edward D., Use of angiogenic lipids for vascularizing tissue.
  41. Roth Bruce D. (Ann Arbor MI), [R-(R*R*)]-2-(4-fluorophenyl)-bd 상세보기

이 특허를 인용한 특허 (20)

  1. McKerracher,Lisa; Lehmann,Maxime, (+)-Trans-4-(1-aminoethyl)-1-(4-pyridycarbamoyl)-cyclohexane and method for promoting neural growth in the central nervous system and in a patient at a site of neuronal lesion.
  2. Chou, Tianwei; Okhamafe, Augustus O., Dry blend formulation of tetrahydrobiopterin.
  3. DiPerna, Paul M, Flow regulating stopcocks and related methods.
  4. Moskowitz, Michael A.; Liao, James K.; Ron, Eyal S.; Omstead, Mary Nallin, Increasing cerebral bioavailability of drugs.
  5. DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  6. DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  7. Michaud, Michael; Kruse, Geoffrey A., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  8. Michaud, Michael; Kruse, Geoffrey A., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  9. Verhoef, Erik T.; DiPerna, Paul M.; Rosinko, Mike; Williamson, Mark; Kruse, Geoffrey A.; Ulrich, Thomas R.; Lamb, Phil; Saint, Sean; Michaud, Michael; Trevaskis, William, Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  10. Oppenheimer, Daniel I.; Kakkis, Emil D.; Price, Fredric D.; Dorenbaum, Alejandro; Moser, Rudolf; Groehn, Viola; Egger, Thomas; Blatter, Fritz, Methods and compositions for the treatment of metabolic disorders.
  11. Oppenheimer, Daniel I.; Kakkis, Emil D.; Price, Fredric D.; Dorenbaum, Alejandro; Moser, Rudolf; Groehn, Viola; Egger, Thomas; Blatter, Fritz, Methods and compositions for the treatment of metabolic disorders.
  12. Oppenheimer, Daniel I.; Kakkis, Emil D.; Price, Fredric D.; Dorenbaum, Alejandro; Moser, Rudolf; Groehn, Viola; Egger, Thomas; Blatter, Fritz, Methods and compositions for the treatment of metabolic disorders.
  13. Oppenheimer, Daniel I.; Kakkis, Emil D.; Price, Fredric D.; Dorenbaum, Alejandro; Moser, Rudolf; Groehn, Viola; Egger, Thomas; Blatter, Fritz, Methods and compositions for the treatment of metabolic disorders.
  14. DiPerna, Paul M., Slideable flow metering devices and related methods.
  15. Brown, David, Solute concentration measurement device and related methods.
  16. Jungles, Steven; Henderson, Mark; Sluzky, Victoria; Baffi, Robert, Stable tablet formulation.
  17. Rosinko, Michael J.; Kruse, Geoffrey A.; Harris, Paul, System and method for detecting occlusions in an infusion pump.
  18. Metzmaker, Thomas; Saint, Sean; Michaud, Michael; Rosinko, Michael J.; Swanson, Vance, Systems including vial adapter for fluid transfer.
  19. DiPerna, Paul M., Two chamber pumps and related methods.
  20. Liao, James K., Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization.

문의처: helpdesk@kisti.re.kr전화: 080-969-4114

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로